**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
| 7732-18-5 |Water | Balance | 231-791-2 |
|----------------|--------------------------------------|----------|-----------|
| Not available |5-Bromoisophthalic Acid | 96 | unlisted |
+----------------+--------------------------------------+----------+-----------+
Text for R-phrases: see Section 16
Hazard Symbols: XI
Risk Phrases: 36/37/38
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.The toxicological
properties of this material have not been fully investigated.
Potential Health Effects
Eye:
Causes eye irritation. The toxicological properties of this
material have not been fully investigated.
Skin:
Causes skin irritation. The toxicological properties of this
material have not been fully investigated.
Ingestion:
Causes gastrointestinal irritation with nausea, vomiting and
diarrhea. The toxicological properties of this substance have not
been fully investigated.
Inhalation:
Causes respiratory tract irritation. The toxicological properties of
this substance have not been fully investigated.
Chronic:
No information found.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Vapors may
be heavier than air. They can spread along the ground and collect
in low or confined areas.
Extinguishing Media:
In case of fire, use water, dry chemical, chemical foam, or
alcohol-resistant foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective
Equipment section. Sweep up, then place into a suitable container for
disposal. Avoid generating dusty conditions. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Avoid contact with eyes, skin, and clothing. Keep
container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a cool, dry place. Keep container closed when not in use.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use process enclosure,
local exhaust ventilation, or other engineering controls to control
airborne levels.
Exposure Limits
CAS# 7732-18-5:
CAS# 23341-91-9:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to minimize
contact with skin.
Respirators:
Wear a NIOSH/MSHA or European Standard EN 149
approved full-facepiece airline respirator in the
positive pressure mode with emergency escape
provisions.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Solid
Color: white to off-white
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 276.00 - 287.00 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: N/A
Explosion Limits, upper: N/A
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C8H5BrO4
Molecular Weight: 245.03
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, irritating and toxic fumes and gases, carbon
dioxide, hydrogen bromide, bromine fumes, bromine.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 7732-18-5: ZC0110000
CAS# 23341-91-9 unlisted.
LD50/LC50:
CAS# 7732-18-5: Oral, rat: LD50 = >90 mL/kg.
CAS# 23341-91-9.
Carcinogenicity:
Water -
Not listed by ACGIH, IARC, or NTP.
5-Bromoisophthalic Acid -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 7732-18-5: No information available.
CAS# 23341-91-9: No information available.
Canada
CAS# 7732-18-5 is listed on Canada's DSL List.
CAS# 7732-18-5 is not listed on Canada's Ingredient Disclosure List.
CAS# 23341-91-9 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 7732-18-5 is listed on the TSCA inventory.
CAS# 23341-91-9 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
Text for R-phrases from Section 2
MSDS Creation Date: 5/13/1998 Revision #2 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
2-Amino-4'-Methylbenzophenone, 99%
| 36192-63-9 |
|
2-Thiophenecarbonyl chloride, 98%
| 5271-67-0 |
|
Hexanoyl chloride, 97%
| 142-61-0 |
|
N-Benzoyl-L-Tyrosine Ethyl Ester, 99%
| 3483-82-7 |
|
4,5-Dimethyl-2-Oxo-1,3,2-Dioxathiolane
| 4440-90-8 |
|
4-Octylphenyl 2-Chloro-4-(4-Heptylbenzoyl-oxy)Benzoate
| 41161-57-3 |
|
3,5-Dimethylaniline, 98%
| 108-69-0 |
|
Methyl 5-Chloropentanoate, 97%
| 14273-86-0 |
|
2',5'-Dihydroxyacetophenone 97%
| 490-78-8 |
|
n-Ethyl-2,3-xylidine, 99%
| 41115-23-5 |
|
3(and 4)-(Vinylbenzyl)-2-Chloroethyl Sulfone, 99% (Titr.)
| |
|
3-(Trifluoromethyl)phenylacetonitrile, 97+ %
| 2338-76-3 |
|
Methyl (1R,3S)-2,2-Dimethyl-3-(2-Oxopropyl )-Cyclopropaneacetate, 96%
| 54878-01-2 |
|
Methyl Benzenesulfonate, 99% (HPLC)
| 80-18-2 |
|
2-Ethoxybenzyl alcohol, 98%
| 71672-75-8 |
|
Zinc sulfide, 99.99%, < 10 microns
| 1314-98-3 |
|
2,5-Dimethoxybenzaldehyde, 97%
| 93-02-7 |
|
2,4,6-Trichloroaniline, 98.5%
| 634-93-5 |
|
Chrysin
| 480-40-0 |
|
5-Hydroxy-1-methyl-3-trifluoromethyl-1H-pyrazole, 99+%
| 122431-37-2 |
|
Dicyclohexano-24-Crown-8, 97%
| 17455-23-1 |
|
Neutron activation standard, short irradiation
| |
|
2,6-Di-Tert- Butylphenol (Pract)
| 128-39-2 |
|
5-Bromoisophthalic Acid, 96% (Titr.)
| 7732-18-5 |
|
Palladium Atomic Absorption Standard Solution, 1mg/ml Pd in 10% HCl.
| 7440-05-3 |
|
(Acetic anhydride)-d6, 98.5 atom % D
| 108-24-7 |
|
3,6-Dihydroxynaphthalene-2,7-Disulfonic Acid, Disodium Salt, Tech.,
| 7153-21-1 |
|
4-Chloro-2-Methylaniline, 99%
| 95-69-2 |
|
o-Tolyl Isothiocyanate, 99%
| 614-69-7 |
|
1-(Dimethylamino)-Pyrrole 99%
| 78307-76-3 |
|
Picrolonic Acid, 93% (Titr.)
| 550-74-3 |
|
2-Chloro-4-Fluorophenol, 97+%
| 1996-41-4 |
|
Bis(2-Ethoxyethyl) Sebacate, 93% (GC)
| 624-10-2 |
|
4-tert-Butylcalix (6) Arene
| 78092-53-2 |
|
2-Iodobenzoic acid, 98%
| 88-67-5 |
|
p-Aminomethylated polystyrene: 1% divinylbenzene copolymer beads
| 0-00-1 |
|
1-(2-Furoyl)piperazine, 98%
| 40172-95-0 |
|
DL-Tropic Acid, 97%
| 529-64-6 |
|
2,3-Dihydroxybenzoic acid, 99%
| 303-38-8 |
|
Methyl alcohol-d, 99.5+ atom % D
| 67-56-1 |
|
Paraffin Liquid, Suitable for Nujol Mull Preparations for IR-Spect.
| 8042-47-5 |
|
N,n'-dicyclohexylurea, 98%
| 2387-23-7 |
|
1,2-Naphthoquinone-4-sulfonic acid potassi um salt, tech., 90%
| 5908-27-0 |
|
1,3-Benzenedimethanol, 98%
| 626-18-6 |
|
3-Hydroxy-4-methyl-2(3H)-thiazolethione, 97%
| 49762-08-5 |
|
(R)-2-Methyl glycidol
| 86884-89-1 |
|
(4S,2RS)-2-Methylthiazolidine-4-carboxylic acid, 97%
| 0-01-1 |
|
8-Anilino-1-naphthalenesulfonic acid ammonium salt, 95% (uv-vis)
| 28836-03-5 |
|
Bismuth Pentafluoride, 99%
| 7787-62-4 |
|
2-Vinylpyridine, 97%, stabilized with 0.1% tert-butylcatechol
| 100-69-6 |
|
|